Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
Ana Carolina CardosoCristiane Valle TovoNathalie Carvalho LeiteIbrahim A El BachaFernanda Luiza CalçadoGabriela Perdomo CoralGlauco Navas SammarcoClaudia CravoRoberto José Carvalho FilhoRenata de Mello PerezRonir Raggio LuizEdison Roberto PariseCristiane Alves Villela NogueiraPublished in: Digestive diseases and sciences (2022)
FAST score has a good performance in a Brazilian NAFLD population, even in patients with higher BMI when the XL probe is adopted. Therefore, FAST can be used as a noninvasive screening tool mainly for excluding the diagnosis of progressive NASH, reducing the number of unnecessary liver biopsies.